Clinical Trial Update: A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a three-drug combination of Bleximenib, Venetoclax, and Azacitidine for newly diagnosed acute myeloid leukemia; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Bleximenib (Bleximenib)
• Venetoclax (venetoclax)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Leukemia, Myeloid, Acute | Phase 3 | Status: RECRUITING